All Pharma News
price-trendAsk Us
Biocad`s BCD-021 Bevacizumab Biosimilar Demonstrates Equivalence in NSCLC

Biocad`s BCD-021 Bevacizumab Biosimilar Demonstrates Equivalence in NSCLC
FIRSTWORDPHARMA
19 Sep 2021
Share Share
Biocad discussing potential COVID-19 vaccine production in China

Biocad discussing potential COVID-19 vaccine production in China
Polina Ivanova REUTERS
27 Jul 2020
Share Share
Russia registers new drug to contain complications caused by COVID-19

Russia registers new drug to contain complications caused by COVID-19
CGTN
07 Jun 2020
Share Share
BIOCAD rituximab biosimilar to receive market authorisation in India

BIOCAD rituximab biosimilar to receive market authorisation in India
MANUFACTURING
04 Jul 2017
Share Share
BIOCAD registered the first rituximab biosimilar in Bolivia and Honduras

BIOCAD registered the first rituximab biosimilar in Bolivia and Honduras
BUSINESSWIRE
05 Jun 2017
Share Share
Roche Wants Russian Co., Counsel Penalized For Drug Suit

Roche Wants Russian Co., Counsel Penalized For Drug Suit
M. Guarnaccia LAW
10 Mar 2017
Share Share
BIOCAD develops rheumatoid arthritis drug, BCD-121

BIOCAD develops rheumatoid arthritis drug, BCD-121
PHARMABIZ
11 Jul 2016
Share Share
Biocad ships Herceptin biosimilar to Sri Lanka

Biocad ships Herceptin biosimilar to Sri Lanka
Gareth MacDonald+ BIOPHARMA REPORTER
30 Mar 2016
Share Share
BIOCAD Score Victory in mAb biosimilar With Market Authorization for Bevacizumab

BIOCAD Score Victory in mAb biosimilar With Market Authorization for Bevacizumab
PR NEWS WIRE
09 Dec 2015
Share Share